Skip to main content

FDA & Regulatory Policy

Medications and personal care items organized on drug store shelves.

Alliance Weighs in on Importance of Treatment Options for Sinus Congestion

September 8, 2023

FDA Sign at its headquarters

Involve Patients More Effectively in the Drug Development Process: Talk NERDY Feedback on FDA’s PFDD Draft Guidance

July 13, 2023

Alliance Celebrates the First-Ever, FDA Traditional Approval of a Disease-Modifying Therapy for Early Alzheimer’s

July 6, 2023

Alliance to Peripheral and Central Nervous System Drugs Advisory Committee: Serve as True Advisors to the FDA’s Expert Review

June 9, 2023

Alliance Statement on CMS’ ‘Plan to Ensure Availability of New Alzheimer’s Drugs’

June 1, 2023

Leading organizations ask FDA advisory committee to consider patient needs in Alzheimer’s-delaying treatments

May 25, 2023

Important News for Older Adults: FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease

May 11, 2023

Alliance and Partners Urge FDA Advisory Committee to Listen to Perspectives of Alzheimer’s Patients and Families when Considering Expansion of Brexpiprazole Label

April 14, 2023

Alliance Report: Medicare Using ‘Coverage with Evidence Development’ to Ration Patient Access to FDA-Approved Treatments

February 13, 2023

Alliance for Aging Research Responds to Office of Civil Rights Proposed Rule on Nondiscrimination Protections

October 5, 2022

Alliance Applauds Patient Affordability Provisions in Inflation Reduction Act

September 19, 2022

The Alliance Submits Comments to the CDC and ACIP on the FDA Authorized Novovax COVID-19 Vaccine

July 19, 2022

FDA–2021–D–0789 Diversity Plans to Improve Enrollment of Participants from
Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry

June 21, 2022

Alliance for Aging Research Statement on Confirmation of Dr. Robert Califf as FDA Commissioner

February 15, 2022

Alliance Submits Comments on the Reauthorization of the Prescription Drug User Fee Act VII Commitment Letter

October 28, 2021

Alliance for Aging Research’s Statement on FDA Decision to Approve Alzheimer’s Treatment

June 7, 2021